BSX vs. STE
Compare and contrast key facts about Boston Scientific Corporation (BSX) and STERIS plc (STE).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BSX or STE.
Correlation
The correlation between BSX and STE is 0.43, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
BSX vs. STE - Performance Comparison
Loading data...
Key characteristics
BSX:
1.85
STE:
0.26
BSX:
2.46
STE:
0.66
BSX:
1.40
STE:
1.08
BSX:
2.84
STE:
0.40
BSX:
11.56
STE:
0.80
BSX:
3.81%
STE:
9.04%
BSX:
22.26%
STE:
22.60%
BSX:
-89.15%
STE:
-77.21%
BSX:
-1.24%
STE:
0.00%
Fundamentals
BSX:
$152.31B
STE:
$22.35B
BSX:
$1.37
STE:
$6.22
BSX:
75.15
STE:
36.58
BSX:
2.54
STE:
5.28
BSX:
8.68
STE:
4.14
BSX:
6.86
STE:
3.54
BSX:
$17.55B
STE:
$3.98B
BSX:
$11.79B
STE:
$1.76B
BSX:
$4.09B
STE:
$1.02B
Returns By Period
In the year-to-date period, BSX achieves a 17.40% return, which is significantly lower than STE's 20.41% return. Over the past 10 years, BSX has outperformed STE with an annualized return of 19.28%, while STE has yielded a comparatively lower 14.64% annualized return.
BSX
17.40%
11.28%
19.72%
40.85%
24.75%
19.28%
STE
20.41%
11.69%
12.20%
5.89%
11.34%
14.64%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
BSX vs. STE — Risk-Adjusted Performance Rank
BSX
STE
BSX vs. STE - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Boston Scientific Corporation (BSX) and STERIS plc (STE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
BSX vs. STE - Dividend Comparison
BSX has not paid dividends to shareholders, while STE's dividend yield for the trailing twelve months is around 0.90%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSX Boston Scientific Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
STE STERIS plc | 0.90% | 1.06% | 0.90% | 0.97% | 0.68% | 0.81% | 0.93% | 1.22% | 1.35% | 1.57% | 1.27% | 1.36% |
Drawdowns
BSX vs. STE - Drawdown Comparison
The maximum BSX drawdown since its inception was -89.15%, which is greater than STE's maximum drawdown of -77.21%. Use the drawdown chart below to compare losses from any high point for BSX and STE. For additional features, visit the drawdowns tool.
Loading data...
Volatility
BSX vs. STE - Volatility Comparison
The current volatility for Boston Scientific Corporation (BSX) is 5.80%, while STERIS plc (STE) has a volatility of 9.54%. This indicates that BSX experiences smaller price fluctuations and is considered to be less risky than STE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
BSX vs. STE - Financials Comparison
This section allows you to compare key financial metrics between Boston Scientific Corporation and STERIS plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
BSX vs. STE - Profitability Comparison
BSX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Boston Scientific Corporation reported a gross profit of 3.21B and revenue of 4.66B. Therefore, the gross margin over that period was 68.8%.
STE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, STERIS plc reported a gross profit of 610.33M and revenue of 1.37B. Therefore, the gross margin over that period was 44.5%.
BSX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Boston Scientific Corporation reported an operating income of 921.00M and revenue of 4.66B, resulting in an operating margin of 19.8%.
STE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, STERIS plc reported an operating income of 245.29M and revenue of 1.37B, resulting in an operating margin of 17.9%.
BSX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Boston Scientific Corporation reported a net income of 674.00M and revenue of 4.66B, resulting in a net margin of 14.5%.
STE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, STERIS plc reported a net income of 173.53M and revenue of 1.37B, resulting in a net margin of 12.7%.